innoscripta SE/€1INN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About innoscripta SE
Ticker
€1INN
Sector
Primary listing
XETRA
Industry
Software
Headquarters
Employees
477
ISIN
DE000A40QVM8
Website
innoscripta SE Metrics
BasicAdvanced
€1B
30.90
€3.27
-
-
Price and volume
Market cap
€1B
52-week high
€100.60
52-week low
€82.50
Financial strength
Current ratio
21.746
Quick ratio
20.733
Long term debt to equity
12.692
Total debt to equity
12.692
Dividend payout ratio (TTM)
24.48%
Interest coverage (TTM)
645.46%
Profitability
EBITDA (TTM)
48.949
Gross margin (TTM)
72.97%
Net profit margin (TTM)
41.47%
Operating margin (TTM)
61.83%
Effective tax rate (TTM)
33.08%
Revenue per employee (TTM)
€170,000
Management effectiveness
Valuation
Price to earnings (TTM)
30.902
Price to revenue (TTM)
12.816
Price to book
21.83
Price to tangible book (TTM)
21.87
Price to free cash flow (TTM)
32.429
Free cash flow yield (TTM)
3.08%
Free cash flow per share (TTM)
311.45%
Growth
Bulls say / Bears say
Innoscripta SE has demonstrated strong financial performance, with revenues increasing from EUR 27.3 million in 2022 to EUR 64.7 million in 2024, and an EBIT margin rising to 57.6% in 2024, indicating robust profitability and growth potential. (webdisclosure.com)
The company's successful IPO on May 23, 2025, with an initial share price of EUR 120 and a market capitalization of EUR 1.2 billion, reflects strong investor confidence and provides capital for further expansion. (boerse-frankfurt.de)
Innoscripta's low customer churn rate of less than 2% over the past three years and a customer base exceeding 1,700 across more than twenty industries suggest a resilient and loyal clientele, supporting sustained revenue streams. (webdisclosure.com)
The company's rapid growth may face challenges in maintaining its high EBIT margins as it scales operations and enters new markets, potentially leading to increased operational costs and margin compression. (webdisclosure.com)
Innoscripta's reliance on the German market for a significant portion of its revenue exposes it to regional economic fluctuations and regulatory changes, which could adversely affect its financial performance. (webdisclosure.com)
The company's recent IPO and subsequent share price volatility, with a decline from the initial EUR 120 to EUR 88 by June 4, 2025, may indicate market skepticism about its valuation and future growth prospects. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 27 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for innoscripta SE stock?
innoscripta SE (1INN) has a market cap of €1B as of July 01, 2025.
What is the P/E ratio for innoscripta SE stock?
The price to earnings (P/E) ratio for innoscripta SE (1INN) stock is 30.9 as of July 01, 2025.
Does innoscripta SE stock pay dividends?
No, innoscripta SE (1INN) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next innoscripta SE dividend payment date?
innoscripta SE (1INN) stock does not pay dividends to its shareholders.
What is the beta indicator for innoscripta SE?
innoscripta SE (1INN) does not currently have a Beta indicator.